Tourmaline Bio, Inc.
TRMLDelisted Oct 28, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827506
Tourmaline Bio, Inc. was delisted on Oct 28, 2025; its insiders filed their last Form 4 on Oct 28, 2025; 134 institutions reported holding it in 13F filings for Q3 2025, worth $1.03B in total; no superinvestor held it.
Superinvestors holding TRML, Q3 2025
No superinvestor reported holding TRML in Q3 2025.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of TRML each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2023
0 superinvestors holding at quarter end
- Sold out
- Viking Global Investors
Q3 2022
1 superinvestor holding at quarter end
- Sold out
- HHLR Advisors (Hillhouse)
Q2 2022
2 superinvestors holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (−61.9%)
Q1 2022
2 superinvestors holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (−8.3%)
Q3 2021
2 superinvestors holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (−10.7%)
Q2 2021
2 superinvestors holding at quarter end